Highlights
Profile claimed by owner
About
Immunotherapeutic Approach for Autoimmunity and Life-threatening Allergies
Canopy is a pre-clinical stage biotech developing a new class of biologics that will allow the elimination of antigen-specific immunity, providing non-immunosuppressive, potentially curing treatments to many dozens of autoimmune, allergic, and other antibody-mediated conditions using its proprietary Reverse-Immunization platform.
Identity
| Name | Canopy Immuno-Therapeutics |
|---|---|
| Slug | canopy-immuno-therapeutics |
| Type / kind | startup |
| Crunchbase ID | canopy-immuno-therapeutics |
| Source _id | agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAkNCk9J4KDA |
Status
| Status | active |
|---|---|
| Last update | 2026-05-17 |
Location
| HQ country code | IL |
|---|---|
| HQ region/district | North District |
| HQ city | Haifa |
| HQ address | Haifa, Israel |
Web & social
| Website | https://canopy-biotech.com |
|---|---|
| https://www.linkedin.com/in/kfir-oved-96b2201b |
Classifications
Primary sector Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
Platforms & InterfacesSoftwareArtificial Intelligence
Target customers
Healthcare & Life SciencesLife SciencesBiotechnology
Business models
B2B
Tags
biotechnologyinflammatory-diseasesallergytreatmentsartificial-intelligencesoftware-platformlife-sciencesimmunologyimmuno-theraphydrug-developmentimmunotherapy
Funding
| Total raised | — |
|---|---|
| Current stage | Series A |
Raw source document
Show full JSON (0 KB)
{
"0": "s",
"1": "l",
"2": "i",
"3": "m",
"4": "p",
"5": "a",
"6": "g",
"7": "e",
"8": "s",
"9": "_",
"10": "i",
"11": "m",
"12": "p",
"13": "o",
"14": "r",
"15": "t"
}